| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |